Job Objective:
One sentence summary of the main objective of the job, the most important activities and the means and guidelines to obtain the objectives.
Support and implement EHS procedures, conduct hazard assessments, and ensure adherence to safety regulations at the manufacturing site.
Environment
Internal and external interactions i.e.: with other departments/divisions, international scope, providers, customers)
Internal: Production, Maintenance, Engineering, HR
External: Vendors, Safety Auditors
Key responsibility
Assist with EHS program implementation
Conduct site inspections and risk assessments
Support accident/incident investigations
Maintain safety records and metrics
Deliver safety training to employees
Academic experience required
Bachelors in EHS, Chemical Engineering, or related field
Professional Experience Required
57 years in EHS roles within manufacturing or pharma industry
Computing Skills
MS Office, EHS databases, incident tracking tools
Personal Skills
Analytical, communication, attention to detail
Languages
English and Arabic
Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people.
This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region.
GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which is crucial for the Egyptian healthcare system.
We are combining the expertise of both shareholders to build and operate 20 plasma donation centers throughout Egypt, along with manufacturing facilities including fractionation, purification, and fill-and-finish plants with a processing capacity of up to 1 million liters of plasma annually that can double in the future.
The new manufacturing facility will include a plasma warehouse and a testing laboratory. It will occupy 105,000 square meters strategically located in the administrative capital’s medical city, adjoining various healthcare institutions.
